DE60043624D1 - DNA-Impfung zur Behandlung von Autoimmunerkrankungen - Google Patents
DNA-Impfung zur Behandlung von AutoimmunerkrankungenInfo
- Publication number
- DE60043624D1 DE60043624D1 DE60043624T DE60043624T DE60043624D1 DE 60043624 D1 DE60043624 D1 DE 60043624D1 DE 60043624 T DE60043624 T DE 60043624T DE 60043624 T DE60043624 T DE 60043624T DE 60043624 D1 DE60043624 D1 DE 60043624D1
- Authority
- DE
- Germany
- Prior art keywords
- treatment
- autoimmune diseases
- dna vaccine
- vaccination
- recipient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2026—IL-4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Rehabilitation Therapy (AREA)
- Diabetes (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Transplantation (AREA)
- Hematology (AREA)
- Mycology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US26759099A | 1999-03-12 | 1999-03-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60043624D1 true DE60043624D1 (de) | 2010-02-11 |
Family
ID=23019424
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60023673T Expired - Lifetime DE60023673T2 (de) | 1999-03-12 | 2000-03-10 | Dna-impfung zur behandlung von autoimmunerkrankungen |
DE60043624T Expired - Lifetime DE60043624D1 (de) | 1999-03-12 | 2000-03-10 | DNA-Impfung zur Behandlung von Autoimmunerkrankungen |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60023673T Expired - Lifetime DE60023673T2 (de) | 1999-03-12 | 2000-03-10 | Dna-impfung zur behandlung von autoimmunerkrankungen |
Country Status (9)
Country | Link |
---|---|
EP (3) | EP2177228A1 (de) |
JP (1) | JP2003508346A (de) |
AT (2) | ATE453404T1 (de) |
CA (1) | CA2363269C (de) |
DE (2) | DE60023673T2 (de) |
DK (2) | DK1168923T3 (de) |
ES (2) | ES2338890T3 (de) |
PT (1) | PT1621208E (de) |
WO (1) | WO2000053019A1 (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2301553A1 (de) * | 2001-11-21 | 2011-03-30 | The Board Of Trustees Of The Leland Stanford Junior University | Polynukleotidtherapie |
WO2008066330A1 (en) | 2006-11-30 | 2008-06-05 | Medipost Co., Ltd. | Use of a composition contaning human umbilical cord blood-derived mesenchymal stem cell for inducing differentiation and proliferation of neural precursor cells or neural stem cells to neural cells |
CN100571786C (zh) * | 2007-03-26 | 2009-12-23 | 中国农业大学 | 一种预防和/或治疗自身免疫疾病的疫苗 |
KR20100054711A (ko) * | 2008-11-14 | 2010-05-25 | 메디포스트(주) | 간엽 줄기세포 또는 이의 배양액을 포함하는 신경질환의 예방 또는 치료용 조성물 |
SE535625C2 (sv) | 2010-10-28 | 2012-10-16 | Toleranzia Ab | Nya kompositioner och förfaranden för behandling av autoimmuna och allergiska sjukdomar |
KR101615161B1 (ko) | 2011-02-02 | 2016-04-25 | 메디포스트(주) | 신경질환의 예방 또는 치료를 위한 icam-1의 용도 |
GB201112806D0 (en) * | 2011-07-26 | 2011-09-07 | Bauer Johann | Use of epitopes inducing specific tolerance for the prevention of tissue rejection |
WO2013160865A1 (en) | 2012-04-26 | 2013-10-31 | Toleranzia Ab | Immunotolerizing fusion proteins for treatment of multiple sclerosis |
GB201300684D0 (en) | 2013-01-15 | 2013-02-27 | Apitope Int Nv | Peptide |
KR20170034701A (ko) | 2015-09-21 | 2017-03-29 | 코오롱생명과학 주식회사 | 통증 치료용 조성물 |
US10898590B2 (en) | 2015-09-21 | 2021-01-26 | Kolon Life Science, Inc. | Method for delivery of biological molecule to nervous tissue |
WO2023086969A2 (en) * | 2021-11-12 | 2023-05-19 | Ichor Medical Systems Inc. | Treatment methods |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5891435A (en) * | 1993-04-16 | 1999-04-06 | Research Corporation Technologies, Inc. | Methods and compositions for delaying or preventing the onset of autoimmune disease |
US5939400A (en) * | 1996-02-26 | 1999-08-17 | The Board Of Trustees Of The Leland Stanford Junior University | DNA vaccination for induction of suppressive T cell response |
US6274136B1 (en) * | 1996-05-29 | 2001-08-14 | University Of Southern California | Construction and use of genes encoding pathogenic epitopes for treatment of autoimmune disease |
AU3225097A (en) | 1996-06-03 | 1998-01-05 | Auragen, Inc. | Immunotherapy for autoimmune disease |
-
2000
- 2000-03-10 ES ES05015105T patent/ES2338890T3/es not_active Expired - Lifetime
- 2000-03-10 AT AT05015105T patent/ATE453404T1/de active
- 2000-03-10 ES ES00912207T patent/ES2251974T3/es not_active Expired - Lifetime
- 2000-03-10 DE DE60023673T patent/DE60023673T2/de not_active Expired - Lifetime
- 2000-03-10 JP JP2000603518A patent/JP2003508346A/ja active Pending
- 2000-03-10 PT PT05015105T patent/PT1621208E/pt unknown
- 2000-03-10 DK DK00912207T patent/DK1168923T3/da active
- 2000-03-10 EP EP09014922A patent/EP2177228A1/de not_active Withdrawn
- 2000-03-10 AT AT00912207T patent/ATE308244T1/de active
- 2000-03-10 WO PCT/US2000/006233 patent/WO2000053019A1/en active IP Right Grant
- 2000-03-10 CA CA2363269A patent/CA2363269C/en not_active Expired - Lifetime
- 2000-03-10 DK DK05015105.9T patent/DK1621208T3/da active
- 2000-03-10 DE DE60043624T patent/DE60043624D1/de not_active Expired - Lifetime
- 2000-03-10 EP EP00912207A patent/EP1168923B1/de not_active Expired - Lifetime
- 2000-03-10 EP EP05015105A patent/EP1621208B1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
PT1621208E (pt) | 2010-04-07 |
DK1621208T3 (da) | 2010-05-10 |
ATE453404T1 (de) | 2010-01-15 |
WO2000053019A1 (en) | 2000-09-14 |
EP1621208A1 (de) | 2006-02-01 |
EP1168923A1 (de) | 2002-01-09 |
EP1168923B1 (de) | 2005-11-02 |
ES2338890T3 (es) | 2010-05-13 |
CA2363269A1 (en) | 2000-09-14 |
EP1621208B1 (de) | 2009-12-30 |
EP2177228A1 (de) | 2010-04-21 |
ATE308244T1 (de) | 2005-11-15 |
DE60023673D1 (de) | 2005-12-08 |
CA2363269C (en) | 2012-06-12 |
EP1168923A4 (de) | 2002-06-26 |
DK1168923T3 (da) | 2006-03-20 |
JP2003508346A (ja) | 2003-03-04 |
ES2251974T3 (es) | 2006-05-16 |
DE60023673T2 (de) | 2006-07-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60043624D1 (de) | DNA-Impfung zur Behandlung von Autoimmunerkrankungen | |
HK1078777A1 (en) | Modified vaccinia virus ankara for the vaccination of neonates | |
DK0633929T3 (da) | Fremgangsmåde til in vitro proliferation af dendritcelleforstadier og deres anvendelse til at producere immunogener | |
FI932678A (fi) | Pao alfavirus baserande dna expressionssystem | |
DK0400958T3 (da) | Levende vacciner | |
DE69737969D1 (de) | Dns-impfung zur einleitung einer suppressiven t-zell-antwort | |
EP0253887A1 (de) | Schwache interferondosierung für die erhöhung der impfstoffwirksamkeit. | |
DE60334725D1 (de) | N vitro zur behandlung von tumoren | |
HUP9900681A2 (hu) | TH1/TH2-citokinexpresszió modulálása Ribavirinnel és Ribavirin-analógokkal, aktivált T-limfocitákban | |
Habibi et al. | Cytokine gene expression in healing and non‐healing cases of cutaneous leishmaniasis in response to in vitro stimulation with recombinant gp63 using semi‐quantitative RT–PCR | |
AR026059A1 (es) | Virus de plantas modificadas y metodos para su uso | |
PL1778833T3 (pl) | Sposoby stosowania komórek regeneracyjnych w celu przyspieszania gojenia się ran | |
ATE71662T1 (de) | Einen menschlichen granulozytkoloniereizfaktor fuer die behandlung von leukopenien enthaltende pharmazeutische zubereitung. | |
JP2006514034A5 (de) | ||
WO2006022612A3 (en) | Methods of using regenerative cells in the treatment of stroke and related diseases and disorders | |
BR0109928A (pt) | Uso de um herpes vìrus atenuado, e, método para estimular uma resposta imune em um indivìduo humano ou animal, ou para tratar ou prevenir uma infecção patogênica ou câncer em um indivìduo humano ou animal | |
YU40796A (sh) | Preparati i postupci za tretiranje obolenja koja izazivaju t ćelije | |
ATE447968T1 (de) | Impfung mit immunisolierten und einen immunomodulator produzierenden zellen | |
DE60130775D1 (de) | Stimulierung der neutrophilfunktion zur behandlung von entzündlichen darmerkrankungen | |
DK0538330T3 (da) | Beta-Alethin-anvendelse til celledyrkning og terapi | |
PH23658A (en) | Improved method of treating tumors with autologous lymphokine activated killer,interleukin-2 and an ornithine decarboxylase inhibitor | |
PT1016414E (pt) | Hormona de crescimento humano para estimular a hematopoiese e a reconstituicao imnologica apos transplante de celulas estaminais hematopoieticas em humanos | |
DE60043216D1 (de) | Gm-csf zur behandlung von morbus crohn | |
LLOYD | CELL TO CELL TRANSFER OF INTERFERON-INDUCED ANTIPROLIFERATIVE ACTIVITY IN VITRO AND ANTIVIRAL ACTIVITY IN VIVO. | |
UA36324A (uk) | Спосіб стимуляції гемопоетичної активності кріоконсервованого аломієлотрансплантата |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |